Search Results - "DUSKOVA, Martina"
-
1
Combined Cancer Immunotherapy Against Aurora Kinase A
Published in Journal of immunotherapy (1997) (01-05-2016)“…Aurora kinase A (AURKA) is a centrosomal protein that is overexpressed in a number of human malignancies and can contribute to tumor progression. As we used…”
Get full text
Journal Article -
2
DNA vaccine against human papillomavirus type 16: Modifications of the E6 oncogene
Published in Vaccine (10-02-2010)“…Abstract Since its discovery, DNA vaccination has become an effective strategy for the development of vaccines against cancer including cervical carcinoma…”
Get full text
Journal Article -
3
Antitumor DNA vaccination against the Sox2 transcription factor
Published in International journal of oncology (01-07-2014)“…As cancer stem cells (CSCs) are resistant to chemotherapy, radiotherapy and targeted molecular therapy, immunotherapy of tumors could be aimed at their…”
Get full text
Journal Article -
4
Vaccination with human papillomavirus type 16-derived peptides using a tattoo device
Published in Vaccine (02-06-2009)“…Abstract Tattooing has been shown to be very efficient at inducing immunity by vaccination with DNA vaccines. In this study, we examined the usability of…”
Get full text
Journal Article -
5
Enhancement of DNA vaccine potency against legumain
Published in Journal of immunotherapy (1997) (01-06-2014)“…The asparaginyl endopeptidase legumain that is overexpressed in M2-polarized tumor-associated macrophages has been identified as a suitable target for…”
Get full text
Journal Article -
6
Predictive value of serum cytokine levels in chronic myeloid leukemia patients
Published in Immunology letters (01-11-2016)“…Highlights • Cytokine levels in CML patients at diagnosis and therapy outcome were related. • MCP-1 levels were significantly higher in patients with optimal…”
Get full text
Journal Article -
7
Enhancement of T cell-mediated and humoral immunity of β-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein
Published in International journal of oncology (01-07-2008)“…Therapeutic DNA vaccines against oncogenic infection with human papillomavirus type 16 (HPV16) are mostly targeted against viral oncoproteins E7 and E6. To…”
Get full text
Journal Article -
8
Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients
Published in Acta haematologica (01-01-2017)“…Our work examined the production of intracellular interferon (INF)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-2, and IL-4 by in vitro stimulated CD3+…”
Get more information
Journal Article -
9
Kynurenine and uric acid levels in chronic myeloid leukemia patients
Published in Oncoimmunology (01-03-2015)“…Indoleamine 2,3-dioxygenase 1 (IDO1), IDO2 and tryptophan 2,3-dioxygenase (TDO) represent some of the key immune regulators. Their increased activity has been…”
Get full text
Journal Article -
10
Expression of a recombinant Human papillomavirus 16 E6GT oncoprotein fused to N- and C-termini of Potato virus X coat protein in Nicotiana benthamiana
Published in Plant cell, tissue and organ culture (01-04-2013)“…Infection with Human papillomaviruses (HPVs) is linked to cervical cancer, which is one of the most common cancers found among women worldwide. Despite…”
Get full text
Journal Article -
11
Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells
Published in International journal of oncology (2008)“…One of the gene therapy strategies in oncology is immunization with cancer cells that express various cytokines. We used a thymidine-kinase deficient (cTK-)…”
Get full text
Journal Article -
12
Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect
Published in The journal of gene medicine (01-06-2005)“…Background The E7 oncoprotein of human papillomavirus type 16 (HPV16) is frequently used as a model tumor‐associated antigen. Its immunogenicity has been…”
Get full text
Journal Article -
13
DNA vaccination against bcr-abl-positive cells in mice
Published in International journal of oncology (01-10-2009)“…A series of DNA vaccines based on the bcr-abl fusion gene were developed and tested in mice. Two mouse (BALB/c) bcr-abl-transformed cell lines, B210 and 12B1,…”
Get full text
Journal Article -
14
Effects of endostatin production on oncogenicity and metastatic activity of HPV16-transformed mouse cells: Role of interleukin 1α
Published in International journal of oncology (01-07-2009)Get full text
Journal Article -
15
Combined chemo-and immunotherapy of tumors induced in mice by bcr-abl-transformed cells
Published in Oncology reports (01-03-2009)“…For our experiments we selected two oncogenic, bcr-abl-transformed mouse cell lines, viz. B210 and 12B1. Both cell types are capable of inducing leukemia-like…”
Get full text
Journal Article -
16
Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells
Published in International journal of oncology (01-08-2008)“…Oncolytic virotherapy is a novel approach to cancer treatment. In the present study we tested the ability of reovirus type 3, strain Dearing, to suppress the…”
Get full text
Journal Article -
17
Effects of endostatin production on oncogenicity and metastatic activity of HPV16-transformed mouse cells: role of interleukin 1alpha
Published in International journal of oncology (01-07-2009)“…Two mouse HPV16-transformed cell lines, viz. MK16 cells, which induce metastasizing tumors, and TC-1 cells, which induce non-metastasizing tumors were…”
Get full text
Journal Article -
18
Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells
Published in Oncology reports (01-10-2004)“…HPV16 E6/E7 transformed mouse kidney cells designated MK16/1/IIIABC (MK16) were modified by the insertion of a suicide gene, viz. the thymidine-kinase gene of…”
Get more information
Journal Article -
19
Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2
Published in Oncology reports (01-02-2005)“…A combination of different types of vaccines usually induces enhanced immune responses in comparison to immunization with single vaccines. The highest efficacy…”
Get more information
Journal Article -
20
DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60)
Published in Oncology reports (01-10-2005)“…Vaccine strategies for the treatment of human papillomavirus-induced cervical cancer are based mainly on the human papillomavirus 16 E7 (HPV16 E7) oncoprotein…”
Get more information
Journal Article